Human parainfluenza virus type 3 HN-receptor interaction: Effect of 4-guanidino-neu5Ac2en on a neuraminidase-deficient variant

Journal of Virology

Volumn 75, Issue 16, 2001, Pages 7481-7488

  Porotto, M ^a   Greengard, O ^a   Poltoratskaia, N ^a   Horga, M A ^a   Moscona, A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HN PROTEIN; SIALIC ACID; SIALIDASE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; ZANAMIVIR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL FUSION; CONTROLLED STUDY; DRUG EFFECT; GENE SEQUENCE; HUMAN; HUMAN CELL; NONHUMAN; PARAINFLUENZA VIRUS 3; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; VIRION; VIRUS ADSORPTION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; ENZYME INHIBITORS; GUANIDINES; HELA CELLS; HUMANS; NEURAMINIDASE; PARAINFLUENZA VIRUS 3, HUMAN; PYRANS; RECEPTORS, VIRUS; SIALIC ACIDS; VIRUS REPLICATION; ZANAMIVIR;

EID: 0034909749     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.16.7481-7488.2001     Document Type: Article

References (33)

1. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites
2. Influenza virus neuraminidase: Structure, antibodies, and inhibitors
3. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase
4. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA
5. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections
6. Transfer of an esterase-resistant receptor analog to the surface of influenza C virions in reduced infectivity due to aggregate formation
7. Mechanism of interference mediated by human parainfluenza virus type 3 infection
8. The hemagglutinin-neuraminidase of human parainfluenza virus type 3: Role of the neuraminidase in the viral life cycle
9. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: Receptor recognition is dependent on neuraminidase activity
10. Fusion mutants of Newcastle disease virus selected with monoclonal antibodies to the hemagglutinin-neuraminidase
11. Identification of amino acid residues important to the neuraminidase activity of the HN glycoprotein of Newcastle disease virus
12. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3
13. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding
14. An analysis of the role of neuraminidase in the receptor-binding activity of influenza B virus: The inhibitory effect of Zanamivir on haemadsorption
15. Location of amino acid residues important for the structure and biological function of the haemagglutinin-neuraminidase glycoprotein of Sendai virus by analysis of escape mutants
16. The role of individual oligosaccharide chains in the activities of the HN glycoprotein of Newcastle disease virus
17. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac 2en-derived inhibitors
18. Fusion properties of cells infected with human parainfluenza virus type 3: Receptor requirements for viral spread and virus-mediated membrane fusion
19. Relative affinity of the human parainfluenza virus 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity
20. Analysis of human parainfluenza virus 3 receptor binding variants: Evidence for the use of a specific sialic acid-containing receptor
21. Neuraminidase is essential for fowl plague virus hemagglutinin to show hemagglutinating activity
22. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety
23. Characterization of temperature-sensitive influenza virus mutants defective in neuraminidase
24. Fluorimetric assay of neuraminidase with a sodium 4-methylumbelliferyl-a-D-N-acetylneuraminidase substrate
25. On the inhibition mechanism of the sialidase activity from Newcastle disease virus
26. A single amino acid substitution in the hemagglutinin-neuraminidase of Newcastle disease virus results in a protein deficient in both functions
27. Differences in bovine parainfluenza 3 virus variants studied by sequencing of the genes of viral envelope proteins
28. Rational design of potent sialidase-based inhibitors of influenza virus replication
29. Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses
30. Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: A study by reverse genetics
31. Amino acid substitutions in a conserved region in the stalk of the Newcastle disease virus HN glycoprotein spike impair its neuraminidase activity in the globular domain
32. Synthesis of 2′-(4-methylumbelliferyl)-alpha-D-N-acetylneuraminic acid and detection of skin fibroblast neuraminidase in normal humans and in sialidosis
33. Identification of amino acids involved in the sialidase activity of the mumps virus hemagglutinin-neuraminidase protein